Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 20538040)

1.

The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity.

Yin F, Yao J, Sancheti H, Feng T, Melcangi RC, Morgan TE, Finch CE, Pike CJ, Mack WJ, Cadenas E, Brinton RD.

Neurobiol Aging. 2015 Jul;36(7):2282-95. doi: 10.1016/j.neurobiolaging.2015.03.013. Epub 2015 Apr 1.

PMID:
25921624
2.

Mitochondrial oxygen consumption deficits in skeletal muscle isolated from an Alzheimer's disease-relevant murine model.

Schuh RA, Jackson KC, Schlappal AE, Spangenburg EE, Ward CW, Park JH, Dugger N, Shi GL, Fishman PS.

BMC Neurosci. 2014 Feb 13;15:24. doi: 10.1186/1471-2202-15-24.

3.

Premature menopause and risk of neurological disease: basic mechanisms and clinical implications.

Scott EL, Zhang QG, Vadlamudi RK, Brann DW.

Mol Cell Endocrinol. 2014 May 25;389(1-2):2-6. doi: 10.1016/j.mce.2014.01.013. Epub 2014 Jan 22. Review.

4.

Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.

Ding F, Yao J, Rettberg JR, Chen S, Brinton RD.

PLoS One. 2013 Nov 11;8(11):e79977. doi: 10.1371/journal.pone.0079977. eCollection 2013.

5.

Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathology.

Brownlow ML, Benner L, D'Agostino D, Gordon MN, Morgan D.

PLoS One. 2013 Sep 12;8(9):e75713. doi: 10.1371/journal.pone.0075713. eCollection 2013.

6.

Hippocampal calcium dysregulation at the nexus of diabetes and brain aging.

Thibault O, Anderson KL, DeMoll C, Brewer LD, Landfield PW, Porter NM.

Eur J Pharmacol. 2013 Nov 5;719(1-3):34-43. doi: 10.1016/j.ejphar.2013.07.024. Epub 2013 Jul 17. Review.

7.

Glucocorticoid-dependent hippocampal transcriptome in male rats: pathway-specific alterations with aging.

Chen KC, Blalock EM, Curran-Rauhut MA, Kadish I, Blalock SJ, Brewer L, Porter NM, Landfield PW.

Endocrinology. 2013 Aug;154(8):2807-20. doi: 10.1210/en.2013-1139. Epub 2013 Jun 4.

8.

Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's.

Ding F, Yao J, Zhao L, Mao Z, Chen S, Brinton RD.

PLoS One. 2013;8(3):e59825. doi: 10.1371/journal.pone.0059825. Epub 2013 Mar 26.

9.

Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Yao J, Brinton RD.

Adv Pharmacol. 2012;64:327-71. doi: 10.1016/B978-0-12-394816-8.00010-6. Review.

10.

Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration.

Yin F, Boveris A, Cadenas E.

Antioxid Redox Signal. 2014 Jan 10;20(2):353-71. doi: 10.1089/ars.2012.4774. Epub 2012 Sep 5. Review.

11.

Minireview: translational animal models of human menopause: challenges and emerging opportunities.

Diaz Brinton R.

Endocrinology. 2012 Aug;153(8):3571-8. doi: 10.1210/en.2012-1340. Epub 2012 Jul 9. Review.

12.

Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles.

Zhao L, Morgan TE, Mao Z, Lin S, Cadenas E, Finch CE, Pike CJ, Mack WJ, Brinton RD.

PLoS One. 2012;7(2):e31267. doi: 10.1371/journal.pone.0031267. Epub 2012 Feb 29.

13.

Estrogen neuroprotection and the critical period hypothesis.

Scott E, Zhang QG, Wang R, Vadlamudi R, Brann D.

Front Neuroendocrinol. 2012 Jan;33(1):85-104. doi: 10.1016/j.yfrne.2011.10.001. Epub 2011 Nov 4. Review.

14.

Reporting of sex as a variable in cardiovascular studies using cultured cells.

Taylor KE, Vallejo-Giraldo C, Schaible NS, Zakeri R, Miller VM.

Biol Sex Differ. 2011 Nov 7;2:11. doi: 10.1186/2042-6410-2-11.

15.

Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.

Yao J, Rettberg JR, Klosinski LP, Cadenas E, Brinton RD.

Mol Aspects Med. 2011 Aug;32(4-6):247-57. doi: 10.1016/j.mam.2011.10.005. Epub 2011 Oct 21. Review.

16.
17.

A mitochondrial etiology of Alzheimer and Parkinson disease.

Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, Laferla F, Wallace DC.

Biochim Biophys Acta. 2012 May;1820(5):553-64. doi: 10.1016/j.bbagen.2011.08.008. Epub 2011 Aug 16. Review.

18.

2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.

Yao J, Chen S, Mao Z, Cadenas E, Brinton RD.

PLoS One. 2011;6(7):e21788. doi: 10.1371/journal.pone.0021788. Epub 2011 Jul 1.

19.

Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.

Yao J, Irwin R, Chen S, Hamilton R, Cadenas E, Brinton RD.

Neurobiol Aging. 2012 Aug;33(8):1507-21. doi: 10.1016/j.neurobiolaging.2011.03.001. Epub 2011 Apr 22.

20.

Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.

Yao J, Du H, Yan S, Fang F, Wang C, Lue LF, Guo L, Chen D, Stern DM, Gunn Moore FJ, Xi Chen J, Arancio O, Yan SS.

J Neurosci. 2011 Feb 9;31(6):2313-20. doi: 10.1523/JNEUROSCI.4717-10.2011.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk